Surgery Partners Net Income 2013-2024 | SGRY
Surgery Partners net income from 2013 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Surgery Partners Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-168 |
| 2023 | $-12 |
| 2022 | $-55 |
| 2021 | $-81 |
| 2020 | $-156 |
| 2019 | $-111 |
| 2018 | $-238 |
| 2017 | $-79 |
| 2016 | $9 |
| 2015 | $1 |
| 2014 | $-66 |
| 2013 | $-9 |
| 2012 | $2 |
| Surgery Partners Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-109 |
| 2024-09-30 | $-32 |
| 2024-06-30 | $-16 |
| 2024-03-31 | $-12 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-5 |
| 2023-06-30 | $19 |
| 2023-03-31 | $-25 |
| 2022-12-31 | $-23 |
| 2022-09-30 | $-25 |
| 2022-06-30 | $-18 |
| 2022-03-31 | $12 |
| 2021-12-31 | $0 |
| 2021-09-30 | $-23 |
| 2021-06-30 | $-27 |
| 2021-03-31 | $-31 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-72 |
| 2020-06-30 | $-42 |
| 2020-03-31 | $-37 |
| 2019-12-31 | $-29 |
| 2019-09-30 | $-25 |
| 2019-06-30 | $-29 |
| 2019-03-31 | $-29 |
| 2018-12-31 | $-156 |
| 2018-09-30 | $-29 |
| 2018-06-30 | $-27 |
| 2018-03-31 | $-25 |
| 2017-12-31 | $-40 |
| 2017-09-30 | $-32 |
| 2017-06-30 | $-4 |
| 2017-03-31 | $-3 |
| 2016-12-31 | $17 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $2 |
| 2016-03-31 | $-7 |
| 2015-12-31 | $17 |
| 2015-09-30 | $-3 |
| 2015-06-30 | $-5 |
| 2015-03-31 | $-7 |
| 2014-12-31 | |
| 2014-09-30 | $-7 |
| 2013-12-31 | |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.068B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| Cencora (COR) | United States | $56.251B | 19.57 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| Natera (NTRA) | United States | $20.836B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |